Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 5:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2233–2256 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Sarcoidosis, Pulmonary Arterial Hypertension
Interventions: Iloprost; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Hypertension, Hypercholesterolemia, Diabetes, Medication Adherence
Interventions: Refill synch; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 691 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Bronchopulmonary Dysplasia, Pulmonary Hypertension
Interventions: higher oxygen saturation target using Nellcor pulse oximetry sensors, lower oxygen saturation target using Nellcor pulse oximetry sensors; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 1 Month to 5 Months
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Birmingham, Alabama • New Haven, Connecticut

Conditions: Hypertension
Interventions: telmisartan, valsartan; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 490 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2002
U.S. locations: 16
States / cities: Long Beach, California • Los Angeles, California • Orange, California + 12 more

Conditions: Hypertension
Interventions: Supported HBPM program plus multifaceted implementation strategy, Usual care; Behavioral · Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 23,928 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: New York, New York

Conditions: Hypertension
Interventions: Carvedilol CR, Valsartan; Drug
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension, Interstitial Lung Disease
Interventions: Not listed
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Retina Disease, Glaucoma, Normal
Interventions: Fundus Camera; Device
Lead sponsor: Optos, PLC; Industry
Eligibility: 22 Years and older
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypertension
Interventions: MIND-BP, BOOST; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Glaucoma, Open-Angle
Interventions: Standard Automatic Perimetry Humphrey Field Analyzer, visuALL H, iCare Home Tonometer, Spectralis Optical coherence tomography (OCT); Diagnostic Test
Lead sponsor: Wills Eye; Other
Eligibility: 20 Years to 80 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Respiratory Failure, Intracranial Hypertension
Interventions: Esophageal Balloon catheter; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Not listed
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Hypertension, Overweight, Obesity, Cardiovascular Diseases, Sedentary Behavior, Low Physical Fitness
Interventions: Active older Adults; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 50 Years to 95 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Intra-Abdominal Hypertension
Interventions: Accuryn Foley catheter device; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Hypertension
Interventions: Aliskiren; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 589 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 43
States / cities: Los Angeles, California • Riverside, California • Santa Monica, California + 38 more

Conditions: Open Angle Glaucoma
Interventions: Hydrus Microstent; Device
Lead sponsor: InSight Vision Center Medical Group, Inc; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Fresno, California

Conditions: Heart Failure, Hypertension
Interventions: Not listed
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Imperial, California

Conditions: Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension, Primary Pulmonary Hypertension, Lung Diseases, Carnitine Nutritional Deficiency
Interventions: L-carnitine; Dietary Supplement
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Food Insecurity, Type 2 Diabetes Mellitus (T2DM), Hypertension
Interventions: Medically Tailored Meals, Grocery Prescription, Medically Tailored Meals and Grocery Prescription, Nutritional Counseling; Behavioral
Lead sponsor: Alison Gustafson; Other
Eligibility: 6 Years to 64 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Cardiometabolic Risk Factors, Diabetes, High Blood Pressure, Obesity, Nutrition Security
Interventions: Food is Medicine; Other
Lead sponsor: Tufts University; Other
Eligibility: 21 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Elevated Blood Pressure
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 6 Years to 19 Years
Enrollment: 52 participants
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Hypertension
Interventions: HTN Chat bot; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pulmonary Hypertension, Familial Persistent, of the Newborn
Interventions: placebo, iv sildenafil; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 0 Days to 4 Days
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 20
States / cities: Little Rock, Arkansas • Sacramento, California • Washington D.C., District of Columbia + 8 more

Conditions: Pulmonary Hypertension
Interventions: blood draw, Short Performance Physical Battery, Grip strength test, Six minute walk test, Chest CT scan, Dual-Energy X-ray Absorptiometry Scan, Activity monitoring, 24 hour diet recall, Echocardiogram, Quality of Life Questionnaire (emPHasis 10), International Physical Activity Questionnaire Short Form (IPAQ-SF); Diagnostic Test · Radiation · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Providence, Rhode Island

Conditions: Hypertension in Pregnancy, Chronic Hypertension, Gestational Hypertension
Interventions: Moms@Home, Enhanced Standard of Care; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Worcester, Massachusetts

Search by objective public record fields.

Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension

The Effect of Synching Prescription Refills on Adherence

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

Implementing a Home Blood Pressure Monitoring Program in Primary Care

Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril

MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension

Optic Disc Photograph Collection Study

Jackson Heart Study Women's Hypertension Study

Evaluating Home Testing Devices for the Management of Glaucoma

Safety of Optimal PEEP in NSICU Patients

Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study

Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter

8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension

Hydrus Microstent as a Quality of Life Consideration

Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals

Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension

Food Insecurity, Social Determinants of Health

Delta GREENS Food is Medicine Intervention

Office, Home, and Ambulatory Blood Pressure

BP PAL - Hypertension Chat Bot Pilot

A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy